» Articles » PMID: 28302910

New Insights into Autophagosome-lysosome Fusion

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2017 Mar 18
PMID 28302910
Citations 257
Authors
Affiliations
Soon will be listed here.
Abstract

Macroautophagy (autophagy) is a highly conserved intracellular degradation system that is essential for homeostasis in eukaryotic cells. Due to the wide variety of the cytoplasmic targets of autophagy, its dysregulation is associated with many diseases in humans, such as neurodegenerative diseases, heart disease and cancer. During autophagy, cytoplasmic materials are sequestered by the autophagosome - a double-membraned structure - and transported to the lysosome for digestion. The specific stages of autophagy are induction, formation of the isolation membrane (phagophore), formation and maturation of the autophagosome and, finally, fusion with a late endosome or lysosome. Although there are significant insights into each of these steps, the mechanisms of autophagosome-lysosome fusion are least understood, although there have been several recent advances. In this Commentary, we will summarize the current knowledge regarding autophagosome-lysosome fusion, focusing on mammals, and discuss the remaining questions and future directions of the field.

Citing Articles

Aniline TFPA enhances camptothecin-induced anti-NSCLC by modulating oxidative stress and impairing autophagy.

Chou H, Lin I, Chen Y, Chang W, Yu A, Chen W Cancer Cell Int. 2025; 25(1):81.

PMID: 40055698 PMC: 11887371. DOI: 10.1186/s12935-025-03657-6.


Tetrandrine augments melanoma cell immunogenicity via dual inhibition of autophagic flux and proteasomal activity enhancing MHC-I presentation.

He L, Liu Y, Jiang J, Wang D, Li Y, Zeng S Acta Pharmacol Sin. 2025; .

PMID: 40016522 DOI: 10.1038/s41401-025-01507-9.


Molecular mechanisms of autophagy and implications in liver diseases.

Wu Y, Tan H, Lin J, Shen H, Wang H, Lu G Liver Res. 2025; 7(1):56-70.

PMID: 39959698 PMC: 11792062. DOI: 10.1016/j.livres.2023.02.002.


Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy.

Meyer-Jens M, Wenzel K, Grube K, Rudebusch J, Kramer E, Bahls M J Mol Cell Cardiol Plus. 2025; 7():100059.

PMID: 39802437 PMC: 11708427. DOI: 10.1016/j.jmccpl.2023.100059.


Deacetylated SNAP47 recruits HOPS to facilitate autophagosome-lysosome fusion independent of STX17.

Jian F, Wang S, Tian W, Chen Y, Wang S, Li Y Nat Commun. 2025; 16(1):543.

PMID: 39788987 PMC: 11718230. DOI: 10.1038/s41467-025-55906-x.